CMS TAVR Technology 
CardiacWire
JULY 28, 2024
Edwards Lifesciences is going all-in on structural heart and heart failure, acquiring aortic valve-maker JenaValve Technology and implantable heart failure monitor company Endotronix for $1.2B and up to $445M in milestone payments.
Society of Thoracic Surgeons - Technology
OCTOBER 21, 2021
After a medical device or intervention has been proven to be safe and effective and reasonable and necessary for coverage, CED requires innovators to monitor how their technology performs in the real world. This process leads to earlier and safer patient access to new technologies and a more direct pathway to coverage for innovators.
Expert insights. Personalized for you.
59 
Let's personalize your content